Clinical Trials Directory

Trials / Unknown

UnknownNCT06174480

Evaluation of the Response to Hypoxia at Rest and During Exercise in a Healthy Subject After a Cryostimulation Exposure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Many information is available regarding human adaptations to cold or hypoxia. Adaptations to these environments and physical exercise constitute responses to physiological stress aimed at amplifying the organism's reactions and improving its performance. However, studies conducted so far to understand these adaptations and their underlying mechanisms have been organized in a dissociated manner, with each study focusing on only one of these specific situations (cold, hypoxia, or exercise). Understanding cross-adaptations is crucial, as human beings are often simultaneously exposed to several of these stimuli, and understanding this cross-exposure can be considered a prerequisite for pre-acclimatization strategies to these different environments. Cross-adaptations has been defined as follows: "It simply involves considering that long-term exposure (either continuous or intermittent) to a given unfavorable environment not only increases tolerance to that particular environment but also leads to gains or losses of tolerance to other unfavorable factors that the adapted organism had never encountered before." When specifically examining cross-adaptations to cold and hypoxia, only one study focusing on the human model is available. The lack of perspectives and positions regarding the results calls for further investigations. The main objective of this study is to assess the effect of repeated exposures to cryostimulation on the variation of the respiratory exchange ratio in hypoxia during exercise.

Conditions

Interventions

TypeNameDescription
OTHERCryostimulationCryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks.

Timeline

Start date
2024-01-25
Primary completion
2025-02-25
Completion
2025-05-25
First posted
2023-12-18
Last updated
2024-01-26

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06174480. Inclusion in this directory is not an endorsement.